140 related articles for article (PubMed ID: 7865616)
1. Tissue polypeptide antigen and tissue polypeptide specific antigen in primary breast cancer. Evaluation in serum and tumour tissue.
Gion M; Mione R; Barioli P; Sartorello P; Capitanio G
Eur J Clin Chem Clin Biochem; 1994 Oct; 32(10):779-87. PubMed ID: 7865616
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of BEKI TPS radioassay kit as a one-step immunoradiometric assay utilizes monoclonal and polyclonal antibodies specific for serum tissue polypeptide antigen].
Hamase A; Kawanaka M; Kitani H; Fukuchi M
Kaku Igaku; 1994 Aug; 31(8):995-1003. PubMed ID: 7933689
[TBL] [Abstract][Full Text] [Related]
3. Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCA.
Gion M; Mione R; Gatti C; Dittadi R; Leon A; Nascimben O; Pizzorno B; Bruscagnin G
Tumori; 1990 Aug; 76(4):360-4. PubMed ID: 2399565
[TBL] [Abstract][Full Text] [Related]
4. [A basic and clinical evaluation of a new immunoradiometric assay kit for human serum tissue polypeptide antigen (TPA)].
Shimojo K; Watanabe N; Sakai S; Kobayashi M; Ohtake H; Hatori N; Fukasawa K; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1996 Jun; 33(6):655-61. PubMed ID: 8741511
[TBL] [Abstract][Full Text] [Related]
5. Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen.
Correale M; Arnberg H; Blockx P; Bombardieri E; Castelli M; Encabo G; Gion M; Klapdor R; Martin M; Nilsson S
Int J Biol Markers; 1994; 9(4):231-8. PubMed ID: 7836801
[TBL] [Abstract][Full Text] [Related]
6. Development of a new Prolifigen TPA IRMA assay using monoclonal anti-cytokeratin antibodies.
Sundström BE; D'Amico Y; Brundell J
Int J Biol Markers; 1995; 10(3):166-73. PubMed ID: 8551060
[TBL] [Abstract][Full Text] [Related]
7. Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic indicator.
Gion M; Mione R; Pappagallo GL; Gatti C; Nascimben O; Brandes A; Vinante O; Bruscagnin G
Eur J Cancer; 1992; 29A(1):66-9. PubMed ID: 1445748
[TBL] [Abstract][Full Text] [Related]
8. Serum TPS versus TPA in Egyptian bladder cancer patients.
Halim AB; el-Ahmady O; Hamza S; Aboul-Ela M; Oehr P
Int J Biol Markers; 1993; 8(4):221-6. PubMed ID: 7511149
[TBL] [Abstract][Full Text] [Related]
9. [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit].
Sakahara H; Endo K; Torizuka K; Itoh K; Ohuchi N; Inaba N; Miyaji Y; Takayama M; Ishii K; Takagi H; Konishi J; Fukuoka M; Fukuchi M; Ohkawa J; Kagawa S; Kondo S; Shirouzu K; Iguchi H
Gan To Kagaku Ryoho; 1996 May; 23(6):733-43. PubMed ID: 8645025
[TBL] [Abstract][Full Text] [Related]
10. A novel IRMA and ELISA for quantifying cytokeratin 8 and 18 fragments in the sera of healthy individuals and cancer patients.
Silén A; Wiklund B; Andersson EL; Nilsson S
Scand J Clin Lab Invest; 1995 Apr; 55(2):153-61. PubMed ID: 7545308
[TBL] [Abstract][Full Text] [Related]
11. Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancer.
Gion M; Mione R; Gatti C; Dittadi R; Leon A; Castiglioni C; Nascimben O; Bruscagnin G
Breast Cancer Res Treat; 1990 Nov; 17(1):15-21. PubMed ID: 1965704
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer.
Stieber P; Schmeller N; Schambeck C; Hofmann K; Reiter W; Hasholzner U; Fateh-Moghadam A
Anticancer Res; 1996; 16(6B):3793-8. PubMed ID: 9042259
[TBL] [Abstract][Full Text] [Related]
14. TPA-cyk assay in cytosol from primary breast cancer: preliminary results.
Correale M; Tedone T; Abbate I; Zotti P; Nassi A; Paradiso A; Schittulli F; De Lena M
Int J Biol Markers; 1994; 9(4):264-5. PubMed ID: 7530753
[No Abstract] [Full Text] [Related]
15. Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.
Gion M; Mione R; Dittadi R; Fasan S; Pallini A; Bruscagnin G
Cancer; 1986 Mar; 57(5):917-22. PubMed ID: 3943025
[TBL] [Abstract][Full Text] [Related]
16. In vitro effect of contrast agents during immunoradiometric assay for tumour-associated antigens.
Watanabe N; Oriuchi N; Higuchi T; Yukihiro M; Fukushima Y; Tomiyoshi K; Hirano T; Inoue T; Endo K
Nucl Med Commun; 1998 Jan; 19(1):63-70. PubMed ID: 9515548
[TBL] [Abstract][Full Text] [Related]
17. [An immunoradiometric assay of the serum TPA from patients with primary lung cancer and a comparison with the conventional double antibody method].
Suzuki K; Reshad K; Akiyama J; Itoi K; Hirata T; Muro K
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jun; 27(6):703-11. PubMed ID: 2552212
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin tumor marker levels in bronchial washing in the diagnosis of lung cancer.
Trevisani L; Putinati S; Sartori S; Abbasciano V; Bagni B
Chest; 1996 Jan; 109(1):104-8. PubMed ID: 8549168
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumour markers in lung cancer.
Stieber P; Dienemann H; Hasholzner U; Müller C; Poley S; Hofmann K; Fateh-Moghadam A
Eur J Clin Chem Clin Biochem; 1993 Oct; 31(10):689-94. PubMed ID: 7507359
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of TPA-assay kit using monoclonal antibodies].
Saga T; Sakahara H; Kousaka T; Yao Z; Nakamoto Y; Hattori N; Zhang M; Nakayama M; Ohshio G; Imamura M; Konishi J
Gan To Kagaku Ryoho; 1996 Apr; 23(5):615-21. PubMed ID: 8678521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
